The Clinical and Translational Science Award (CTSA) partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System is now accepting applications for the 12-month Pilot Translational and Clinical Studies Program.

Locally, the CTSA partners administer the grants through the integrated Translational Health Research Institute of Virginia (iTHRIV). Applications from scientists and clinical professionals from any iTHRIV institution are due by Aug. 31, 2020.

The Pilot Translational and Clinical Studies Program is designed to help researchers transition from early stage seed grants and proof-of-concept studies to translational research and clinical application. Successful applicants will receive funding starting in February 2021. Single-institution teams may request up to $25,000 in direct costs, and multi-institution teams may request up to $50,000 in direct costs.

Translational or clinical projects that involve data science or innovative analytical approaches and involve collaborations across iTHRIV partner institutions are encouraged. Earlier this year, iTHRIV awarded pilot funding to multi-institutional teams of scientists, physicians, and engineers to explore new machine learning approaches to cancer cell recognition, shoulder surgery recovery recommendations, depression treatments, and what causes an inflammatory throat disease.

iTHRIV combines the expertise of biomedical researchers and data scientists to create resources for using data to improve health across the Commonwealth of Virginia. The institute is supported by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, through award number UL1TR003015.

For more information about the Pilot Translational and Clinical Studies Program and request for proposals, please visit the iTHRIV website or register to attend a virtual information session occurring on July 9 at 3 p.m.